Compare Kenvue Inc. Common Stock (KVUE) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kenvue Inc. Common Stock vs State Street SPDR S&P Biotech ETF — how do they compare? Kenvue Inc. Common Stock trades at $17.64 (market cap $34.06B), while State Street SPDR S&P Biotech ETF trades at $153.72 (market cap $10.11B). The key difference: Kenvue Inc. Common Stock is far larger — about 3.4× State Street SPDR S&P Biotech ETF's market cap, and Kenvue Inc. Common Stock pays a 4.74% dividend while State Street SPDR S&P Biotech ETF pays none. Which is the better fit depends on your goals.
| KVUE | XBI | |
|---|---|---|
Market Cap | $34.06B | $10.11B |
Volume | 23,267,228 | 12,903,266 |
Sector | Consumer Staples | Broad Market / Factor |
52-Week High | $19.83 | $169.55 |
52-Week Low | $14.11 | $104.99 |
Enterprise Value | $41.56B | — |
Dividend Yield | 4.74% | — |
Typical Hold Time | — | 38 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
XBI trades at $153.84, up 2.4% today, but technical indicators signal a bearish trend with resistance at $154. The ETF's modified equal-weight structure offers broad biotech exposure, benefiting from M&A activity and positive clinical catalysts, though key financial ratios are unavailable. Recent news highlights sector optimism driven by cancer vaccine breakthroughs and improved capital access.
Outlook is mixed: bullish sentiment from innovation and M&A supports growth potential, but high volatility and expense ratios relative to peers pose risks. Analyst consensus is neutral (100% Hold), suggesting cautious optimism amid technical bearishness.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kenvue Inc. Common Stock
Kenvue is a consumer health company that markets personal care, self-care, and skin health products. Its brands include Tylenol, Listerine, Neutrogena, Johnson’s, BAND-AID Brand, Aveeno, and Zyrtec.
Read more on KVUE →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
